MK-6552

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MK-6552, covering 2024-10-01 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004) [Phase 1]